Category: New products
-
Challenge Trial Testing Covid-19 Reinfection
A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.
-
Synthetic DNA Company Raises $24M in Early Funds
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round.
-
Mobile App Studied to Measure Kidney Disease Anemia
A smartphone app designed to non-invasively estimate hemoglobin levels is being assessed for its ability to measure anemia in chronic kidney disease patients.
-
Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-
Antibody Cocktail Prevents Covid-19 Disease Symptoms
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients.
-
First U.S. Quantum Tech Incubator Underway
The first incubator program in the U.S. for start-up enterprises developing quantum technologies is now accepting applicants in Chicago.
-
NIH Trial Testing mRNA Vaccine Allergic Effects
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response.
-
Small Biz Grant Funds Wrist Fracture Adhesive
A company developing a biocompatible material to aid bone healing will test the substance on treating simulated wrist fractures in large animals.
-
Trial Shows Inhaled Covid-19 Therapy Safe
Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers.